131 related articles for article (PubMed ID: 37531271)
1. Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study.
Gong IY; Cheung MC; Chan KKW; Arya S; Faught N; Calzavara A; Liu N; Odejide OO; Abel G; Kurdyak P; Raphael MJ; Kuczmarski T; Prica A; Mozessohn L
J Natl Cancer Inst; 2023 Oct; 115(10):1194-1203. PubMed ID: 37531271
[TBL] [Abstract][Full Text] [Related]
2. Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry.
Blunt DN; Smyth L; Nagamuthu C; Gatov E; Croxford R; Mozessohn L; Cheung MC
J Natl Compr Canc Netw; 2021 Mar; 19(6):719-725. PubMed ID: 33691276
[TBL] [Abstract][Full Text] [Related]
3. Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects.
Smyth L; Blunt DN; Gatov E; Nagamuthu C; Croxford R; Mozessohn L; Cheung MC
Br J Haematol; 2020 Nov; 191(3):396-404. PubMed ID: 32304100
[TBL] [Abstract][Full Text] [Related]
4. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
5. Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study.
Kuczmarski TM; Tramontano AC; Mozessohn L; LaCasce AS; Roemer L; Abel GA; Odejide OO
Lancet Haematol; 2023 Jul; 10(7):e530-e538. PubMed ID: 37271158
[TBL] [Abstract][Full Text] [Related]
6. Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma.
Upshaw JN; Nelson J; Rodday AM; Kumar AJ; Klein AK; Konstam MA; Wong JB; Jaffe IZ; Ky B; Friedberg JW; Maurer M; Kent DM; Parsons SK
JAMA Cardiol; 2023 May; 8(5):453-461. PubMed ID: 36988926
[TBL] [Abstract][Full Text] [Related]
7. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
Ren J; Asche CV; Shou Y; Galaznik A
J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
[TBL] [Abstract][Full Text] [Related]
8. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
9. Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study.
Vijenthira A; Mozessohn L; Nagamuthu C; Liu N; Blunt D; Alibhai S; Prica A; Cheung MC
J Natl Compr Canc Netw; 2022 Jun; 20(6):635-642.e9. PubMed ID: 35714676
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B-cell lymphoma.
Habbous S; Guo H; Beca J; Dai WF; Isaranuwatchai W; Cheung M; Chan KKW
Cancer Med; 2020 Oct; 9(19):7072-7082. PubMed ID: 32794362
[TBL] [Abstract][Full Text] [Related]
11. A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data.
Morin KA; Eibl JK; Gauthier G; Rush B; Mushquash C; Lightfoot NE; Marsh DC
Harm Reduct J; 2020 Jul; 17(1):51. PubMed ID: 32703310
[TBL] [Abstract][Full Text] [Related]
12. Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Treatments for Non-Transplant Eligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Matching-Adjusted Indirect Comparison.
Cordoba R; Prawitz T; Westley T; Sharma A; Ambarkhane S; Kapetanakis V; Sabatelli L
Adv Ther; 2022 Jun; 39(6):2668-2687. PubMed ID: 35403948
[TBL] [Abstract][Full Text] [Related]
13. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
Howlader N; Mariotto AB; Besson C; Suneja G; Robien K; Younes N; Engels EA
Cancer; 2017 Sep; 123(17):3326-3334. PubMed ID: 28464214
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular diseases among diffuse large B-cell lymphoma long-term survivors in Asia: a multistate model study.
Lee SF; Vellayappan BA; Wong LC; Chiang CL; Chan SK; Wan EY; Wong IC; Lambert PC; Rachet B; Ng AK; Luque-Fernandez MA
ESMO Open; 2022 Feb; 7(1):100363. PubMed ID: 35026723
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G;
J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China.
Wang S; Wang L; Hu J; Qian W; Zhang X; Hu Y; Zhu Q; Chen B; Wu D; Chang CH; Xu P; Zheng X; Wei J; Liu Y; Cui G; Tang Y; Ma Y; Huang H; Yi H; Zhao W
Cancer Commun (Lond); 2021 Mar; 41(3):229-239. PubMed ID: 33482051
[TBL] [Abstract][Full Text] [Related]
17. Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.
Williams JN; Rai A; Lipscomb J; Koff JL; Nastoupil LJ; Flowers CR
Cancer; 2015 Jun; 121(11):1800-8. PubMed ID: 25675909
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Associations of Mental Disorders With Physical Diseases and Mortality Among 2.3 Million New Zealand Citizens.
Richmond-Rakerd LS; D'Souza S; Milne BJ; Caspi A; Moffitt TE
JAMA Netw Open; 2021 Jan; 4(1):e2033448. PubMed ID: 33439264
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.
Griffiths RI; Gleeson ML; Mikhael J; Dreyling MH; Danese MD
Cancer; 2012 Dec; 118(24):6079-88. PubMed ID: 22648454
[TBL] [Abstract][Full Text] [Related]
20. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region.
Ahmed AH; Foster CS; Shields CL
JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
